Transcriptomics

Dataset Information

0

SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence [scRNA-Seq]


ABSTRACT: COVID-19 patients commonly present with neurological signs of central nervous system (CNS) and/or peripheral nervous system dysfunction. However, which neural cells are permissive to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been controversial. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively susceptible and permissive to SARS-CoV-2 infection, and that SARS-CoV-2 infection triggers a DA neuron inflammatory and cellular senescence response. A high-throughput screen in hPSC-derived DA neurons identified several FDA approved drugs, including riluzole, metformin, and imatinib, that can rescue the cellular senescence phenotype by preventing SARS-CoV-2 infection. RNA-seq analysis of human ventral midbrain tissue from COVID-19 patients, using formalin-fixed paraffin-embedded autopsy samples, confirmed the induction of an inflammatory and cellular senescence signature and identified low levels of SARS-CoV-2 transcripts. Our findings demonstrate that hPSC-derived DA neurons can serve as a disease model to study neuronal susceptibility to SARS-CoV-2 and to identify candidate neuroprotective drugs for COVID-19 patients. The susceptibility of hPSC-derived DA neurons to SARS-CoV-2 and the observed inflammatory and senescence transcriptional responses suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE248989 | GEO | 2023/12/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-10-20 | GSE174745 | GEO
2022-10-01 | GSE156761 | GEO
2020-08-11 | GSE155241 | GEO
2020-06-11 | GSE147903 | GEO
2021-01-01 | GSE148697 | GEO
2020-06-12 | GSE151803 | GEO
2020-08-11 | GSE147975 | GEO
2022-02-05 | E-MTAB-10740 | biostudies-arrayexpress
2023-05-01 | GSE206677 | GEO
2021-09-24 | ST001921 | MetabolomicsWorkbench